Refine by
Inflammation Organ Suppliers & Manufacturers
8 companies found
based inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
MPC-300-IV is being developed for the treatment of diabetic complications, including diabetic kidney disease known as diabetic ...
based inGeffen, NETHERLANDS
Avant Medical offers laboratory healthcare professionals advice on making the right choice when it comes to the smartest products in their class. In this way, together we make a significant contribution to improved diagnostics and therefore better ...
The measurement of serum lipase activity is widely used for the diagnosis of acute ...
based inSanta Rosa, CALIFORNIA (USA)
Eliaz Therapeutics is developing a novel treatment using targeted therapeutic apheresis. Our mission is to change the course of life-threatening diseases to improve survival and prevent long-term disease and disability. Eliaz Therapeutics is ...
based inMunich, GERMANY
Leaders in optoacoustic imaging through innovation and collaboration; Optoacoustic imaging is a very complex field, both from a technology and applications perspective. Components to master include lasers, optics, ultrasound detectors, electronics, ...
The inVision is the world’s first imaging system that incorporates transmission ultrasound computed tomography (TUCT). TUCT provides an accurate image of speed of sound in tissue and its change with disease, e.g. in the context of cancer or ...
based inSouth San Francisco, CALIFORNIA (USA)
Superfluid’s platform technology is applicable to a wide variety of diseases. We are currently focused on Alzheimer’s Disease, where there are urgent medical needs. This minimally invasive approach eliminates the need for spinal taps and ...
based inTaipei, TAIWAN
Lumosa Therapeutics is a clinical-stage pharmaceutical company dedicating to develop novel therapies and solutions for neurological and oncological diseases with urgent unmet medical need. Besides of using Lumosa's own technology platform in drug ...
According to the WHO, stroke is the second leading cause of death with approximately 6 million deaths in the world per year. Stroke can be categorized as a hemorrhagic or an ischemic stroke. Studies show ischemic stroke, which LT3001 intends to ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
based inMonmouth Junction, NEW JERSEY (USA)
CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 58 countries around the world, as an extracorporeal ...